Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07132489) titled 'Validation of New Biomarkers for Predicting No-Reflow in STEMI Patients Undergoing Primary PCI' on Aug. 11.
Study Type: Observational [Patient Registry]
Primary Sponsor: Assiut University
Condition:
Myocardial Infarction
No Reflow Phenomenon
Intervention:
Diagnostic Test: HbA1c/C-peptide ratio Albumin-bilirubin (ALBI) score. Neutrophil/HDL ratio...
Recruitment Status: Not recruiting
Date of First Enrollment: September 1, 2025
Target Sample Size: 114
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07132489
Published by HT Digital Content Services with permission from Health Daily Digest....